Sixteen drugmakers, including Bristol-Myers Squibb and Burroughs Wellcome Co., have said they will finance trials to determine if any combination of AIDS drugs appears more effective at battling HIV, the virus that causes AIDS.
The companies formed the Intercompany Collaboration on AIDS Drug Development last year to speed the development of treatments to counter HIV. The virus quickly mutates to resist drugs. Some researchers argue that combinations of drugs attack the virus better than single treatments.
Tests of various combinations will begin in fall. A budget wasn't available.